Ningbo David Medical Device Co (300314) Fair Value & Analysis
Healthcare · CN · Market cap 2.8B CNY
Fair value as of: Jun 24, 2026
Analysis
Ningbo David Medical Device Co (300314) currently trades at ¥9.61, while our model-based Fair Value estimate is ¥6.19 — implying the stock looks roughly 35.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It offers infusion pumps, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, and infant oxygen hoods. The company offers its products under David brand name. The company founded in 1992 and is headquartered in Ningbo, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Ningbo David Medical Device Co (300314) undervalued?
What is the fair value of 300314?
What is the quality score of 300314?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.